re: News: Biotron's Hep C drug candidate phas... It would not surprise me to see a sudden trading halt followed by an announcement that the company has entered an agreement with a major pharmaceutical to fund phase III trials with BIT225. There would also be a project to fast track studies into patients infected with both HIV and HCV.
If this happens the opportunity to invest at these low levels will be lost.
GL to all
Regards
Will
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $1.606K | 803.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 39950557 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 17911809 | 22 |
View Market Depth
| Last trade - 14.19pm 01/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |